EINDHOVEN, Netherlands—Luxexcel, a Dutch company that has developed a technology for 3D printing of ophthalmic lenses, announced it has received up to $10 million in equity financing from a group of financial and strategic investors.

KLA-Tencor Corporation (NASDAQ: KLAC) participated in this round both financially as well as through in-kind industrial cooperation with Luxexcel. The existing financial investors of Luxexcel, SET Ventures from the Netherlands, Germany-based Munich Venture Partners and the Flemish regional investment fund PMV also participate in this round.

“This investment by a group of renowned investors combined with the strategic cooperation with KLA-Tencor is of key importance to our business development,” said Luxexcel CEO Hans Streng. “It enables us to bring high quality industrial 3D printers to the ophthalmic market and it shows great confidence in our business strategy. Ever since our focus on 3D printing of ophthalmic lenses we have experienced an exponentially increasing interest and market pull both from the ophthalmic market as well as related industries such as virtual and augmented reality.

“The cooperation with KLA-Tencor and its global track record in the semiconductor-tooling industry gives a major boost to our smart-glasses roadmap. We are now ready to scale up, deliver and disrupt … exciting times.”

Luxexcel is currently preparing its 3D-printing platform for global shipments to ophthalmic labs in the second half of 2017. The platform consisting of industrial grade 3D-printers, lens-design software and workflow integration tools that the company introduced during Vision Expo East 2017 in New York.